EB
29 May 2021

A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa

 Mol Ther Nucleic Acids. 2021 May 29;25:237-250. doi: 10.1016/j.omtn.2021.05.015. PMID: 34458008; PMCID: PMC8368800. A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa […]
5 September 2022

Stanford Adult Epidermolysis Bullosa Anesthesia Protocol 

PDF Stanford Adult Epidermolysis Bullosa Anesthesia Protocol  Authors:  Erin Bushell, MD and Brita Mittal, MD   Department of Anesthesiology, Perioperative, and Pain Medicine, Stanford University School of […]
29 March 2023

Mapping the burden of severe forms of epidermolysis bullosa – Implications for patient management

JAAD Int. 2023 Mar 29;11:224-232. doi: 10.1016/j.jdin.2023.02.016. PMID: 37179539; PMCID: PMC10173168. Mapping the burden of severe forms of epidermolysis bullosa – Implications for patient management Authors: […]
25 April 2023

Trametinib-Induced Epidermal Thinning Accelerates a Mouse Model of Junctional Epidermolysis Bullosa

Biomolecules. 2023 Apr 25;13(5):740. doi: 10.3390/biom13050740. PMID: 37238610; PMCID: PMC10216840. Trametinib-Induced Epidermal Thinning Accelerates a Mouse Model of Junctional Epidermolysis Bullosa Authors: Grace Tartaglia 1, Pyung Hun Park 1, Michael […]
26 April 2023

A Case of Recessive Dystrophic Epidermolysis Bullosa Associated Colitis

JPGN Rep. 2023 Apr 26;4(2):e313. doi: 10.1097/PG9.0000000000000313. PMID: 37200727; PMCID: PMC10187860. A Case of Recessive Dystrophic Epidermolysis Bullosa Associated Colitis Authors: Katelyn McCann 1, Karen Wiss 1 2, Jeffrey Covington 3, Vanessa Laffert 1, Kerri B Gosselin 1 Affiliation: […]
1 June 2023

Generation and characterization of induced pluripotent stem cell lines from two patients with recessive dystrophic epidermolysis Bullosa

Stem Cell Res. 2023 Jun;69:103104. doi: 10.1016/j.scr.2023.103104. Epub 2023 Apr 24. PMID: 37148821. Generation and characterization of induced pluripotent stem cell lines from two patients with […]
26 June 2023

Gene therapy advances shine the spotlight on epidermolysis bullosa, bringing hope to patients.

Keywords: recent different therapeutic gene therapy strategies
26 June 2023

Characterization of wound microbes in epidermolysis bullosa: A focus on Pseudomonas aeruginosa.

Keywords: epidermolysis bullosa; infection-bacterial; therapy-topical.
4 July 2023

ABSTRACT: Compassionate use of topical beremagene geperpavec (B-VEC) for the treatment of recurrent cicatrizing conjunctivitis in a patient with dystrophic epidermolysis bullosa

Keywords: B-VEC, Krystal, Opthalmology, Gene therapy